Arax Advisory Partners’s GSK GSK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $759K | Buy |
19,753
+12,187
| +161% | +$468K | 0.03% | 300 |
|
2025
Q1 | $293K | Buy |
7,566
+6,152
| +435% | +$238K | 0.02% | 435 |
|
2024
Q4 | $47.8K | Buy |
1,414
+480
| +51% | +$16.2K | ﹤0.01% | 922 |
|
2024
Q3 | $38.2K | Sell |
934
-20
| -2% | -$818 | ﹤0.01% | 816 |
|
2024
Q2 | $36.7K | Sell |
954
-1,642
| -63% | -$63.2K | ﹤0.01% | 758 |
|
2024
Q1 | $111K | Buy |
2,596
+17
| +0.7% | +$729 | 0.01% | 374 |
|
2023
Q4 | $95.6K | Buy |
2,579
+101
| +4% | +$3.74K | 0.01% | 388 |
|
2023
Q3 | $89.8K | Buy |
2,478
+565
| +30% | +$20.5K | 0.01% | 367 |
|
2023
Q2 | $68.2K | Buy |
1,913
+823
| +76% | +$29.3K | 0.01% | 417 |
|
2023
Q1 | $38.8K | Buy |
1,090
+377
| +53% | +$13.4K | 0.01% | 495 |
|
2022
Q4 | $25.1K | Hold |
713
| – | – | ﹤0.01% | 535 |
|
2022
Q3 | $21K | Buy |
713
+38
| +6% | +$1.12K | ﹤0.01% | 562 |
|
2022
Q2 | $37K | Hold |
675
| – | – | 0.01% | 468 |
|
2022
Q1 | $37K | Sell |
675
-27
| -4% | -$1.48K | ﹤0.01% | 492 |
|
2021
Q4 | $39K | Buy |
702
+27
| +4% | +$1.5K | ﹤0.01% | 487 |
|
2021
Q3 | $32K | Buy |
675
+13
| +2% | +$616 | ﹤0.01% | 502 |
|
2021
Q2 | $33K | Buy |
+662
| New | +$33K | ﹤0.01% | 525 |
|
2020
Q4 | $30K | Hold |
662
| – | – | ﹤0.01% | 460 |
|
2020
Q3 | $31K | Hold |
662
| – | – | 0.01% | 434 |
|
2020
Q2 | $34K | Buy |
662
+182
| +38% | +$9.35K | 0.01% | 414 |
|
2020
Q1 | $23K | Hold |
480
| – | – | 0.01% | 442 |
|
2019
Q4 | $28K | Hold |
480
| – | – | 0.01% | 388 |
|
2019
Q3 | $26K | Hold |
480
| – | – | 0.01% | 392 |
|
2019
Q2 | $24K | Buy |
+480
| New | +$24K | 0.01% | 395 |
|
2018
Q4 | $27K | Sell |
563
-223
| -28% | -$10.7K | 0.01% | 341 |
|
2018
Q3 | $39K | Sell |
786
-1,605
| -67% | -$79.6K | 0.02% | 310 |
|
2018
Q2 | $120K | Buy |
2,391
+96
| +4% | +$4.82K | 0.05% | 139 |
|
2018
Q1 | $112K | Buy |
2,295
+885
| +63% | +$43.2K | 0.06% | 125 |
|
2017
Q4 | $62K | Buy |
1,410
+72
| +5% | +$3.17K | 0.03% | 194 |
|
2017
Q3 | $67K | Sell |
1,338
-152
| -10% | -$7.61K | 0.03% | 183 |
|
2017
Q2 | $76K | Buy |
1,490
+76
| +5% | +$3.88K | 0.04% | 180 |
|
2017
Q1 | $74K | Buy |
1,414
+3
| +0.2% | +$157 | 0.04% | 157 |
|
2016
Q4 | $68K | Buy |
+1,411
| New | +$68K | 0.03% | 140 |
|